TPM4
Tropomyosin alpha-4 chain
Also known as: TPM4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P67936
- Gene
- TPM4
- Ensembl
- ENSG00000167460
- Chromosome
- 19
- Canonical length
- 248 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Actin filaments,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the tropomyosin family of actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosins are dimers of coiled-coil proteins that polymerize end-to-end along the major groove in most actin filaments. They provide stability to the filaments and regulate access of other actin-binding proteins. In muscle cells, they regulate muscle contraction by controlling the binding of myosin heads to the actin filament. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2009]
Canonical amino-acid sequenceUniProt
248 residues, UniProt reviewed canonical sequence.
>P67936|TPM4
1 MAGLNSLEAV KRKIQALQQQ ADEAEDRAQG LQRELDGERE RREKAEGDVA ALNRRIQLVE
61 EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRAMK DEEKMEIQEM QLKEAKHIAE
121 EADRKYEEVA RKLVILEGEL ERAEERAEVS ELKCGDLEEE LKNVTNNLKS LEAASEKYSE
181 KEDKYEEEIK LLSDKLKEAE TRAEFAERTV AKLEKTIDDL EEKLAQAKEE NVGLHQTLDQ
241 TLNELNCILocalizationUniProt · AlphaFold · HPA
Whether an antibody against TPM4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 523 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 523 nTPM
- endometrium: 377 nTPM
- lung: 335 nTPM
- adipose tissue: 294 nTPM
- esophagus: 288 nTPM
- fallopian tube: 279 nTPM
Single-cell type
- megakaryocytes: 4,037 nCPM
- platelets: 3,393 nCPM
- esophageal apical cells: 2,395 nCPM
- neutrophils: 1,467 nCPM
- extravillous trophoblasts: 1,131 nCPM
- decidual stromal cells: 1,114 nCPM
Immune cell
- total PBMC: 158 nTPM
- T-reg: 151 nTPM
- basophil: 132 nTPM
- myeloid DC: 96 nTPM
- gdT-cell: 96 nTPM
- intermediate monocyte: 94 nTPM
Brain region
- cerebellum: 66 nTPM
- thalamus: 57 nTPM
- cerebral cortex: 48 nTPM
- pons: 45 nTPM
- medulla oblongata: 43 nTPM
- spinal cord: 40 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TPM4.
Disease | AllUniProt
Conditions TPM4 is implicated in, by any mechanism.
- Bleeding disorder, platelet-type, 25 (BDPLT25) MIM:620486
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 61 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bleeding disorder, platelet-type, 25
ReferencesPubMed · IEDB
Publications for TPM4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Anti-endothelial cell antibodies in patients with cerebral small vessel disease.
2012 · Curr Neurovasc Res · RCR 0.7 · 22 citations - Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis.
2023 · Rheumatology (Oxford)
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.39
- gnomAD missense Z
- 0.95
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- actin filament binding
- calcium ion binding
- identical protein binding
- protein heterodimerization activity
- protein homodimerization activity
- structural constituent of muscle
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TPM4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TPM4 as an antibody target. Whether an autoantibody or antibody against TPM4 could matter depends on whether native TPM4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TPM4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TPM4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...